ALT
Price
$5.17
Change
-$0.08 (-1.52%)
Updated
May 1 closing price
Capitalization
398.16M
6 days until earnings call
RCKT
Price
$7.86
Change
+$0.23 (+3.01%)
Updated
May 1 closing price
Capitalization
838.11M
10 days until earnings call
Ad is loading...

ALT vs RCKT

Header iconALT vs RCKT Comparison
Open Charts ALT vs RCKTBanner chart's image
Altimmune
Price$5.17
Change-$0.08 (-1.52%)
Volume$2.09M
Capitalization398.16M
Rocket Pharmaceuticals
Price$7.86
Change+$0.23 (+3.01%)
Volume$2.85M
Capitalization838.11M
ALT vs RCKT Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. RCKT commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and RCKT is a Buy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (ALT: $5.25 vs. RCKT: $7.63)
Brand notoriety: ALT and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 69% vs. RCKT: 73%
Market capitalization -- ALT: $398.16M vs. RCKT: $838.11M
ALT [@Biotechnology] is valued at $398.16M. RCKT’s [@Biotechnology] market capitalization is $838.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 3 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than RCKT.

Price Growth

ALT (@Biotechnology) experienced а +5.63% price change this week, while RCKT (@Biotechnology) price change was +6.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.96%. For the same industry, the average monthly price growth was +8.43%, and the average quarterly price growth was -7.58%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+2.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($838M) has a higher market cap than ALT($398M). ALT YTD gains are higher at: -27.184 vs. RCKT (-39.300). ALT has higher annual earnings (EBITDA): -94.81M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. ALT (132M). ALT has less debt than RCKT: ALT (1.68M) vs RCKT (25.5M). ALT has higher revenues than RCKT: ALT (20K) vs RCKT (0).
ALTRCKTALT / RCKT
Capitalization398M838M47%
EBITDA-94.81M-247.48M38%
Gain YTD-27.184-39.30069%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash132M372M35%
Total Debt1.68M25.5M7%
FUNDAMENTALS RATINGS
ALT vs RCKT: Fundamental Ratings
ALT
RCKT
OUTLOOK RATING
1..100
1517
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
8190
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (30) in the Biotechnology industry is significantly better than the same rating for ALT (97) in the Miscellaneous Commercial Services industry. This means that RCKT’s stock grew significantly faster than ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (90) in the Miscellaneous Commercial Services industry is in the same range as RCKT (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as RCKT (97) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's Price Growth Rating (81) in the Miscellaneous Commercial Services industry is in the same range as RCKT (90) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as RCKT (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTRCKT
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.860.60
+2.20%
GameStop Corp
AAPL212.501.29
+0.61%
Apple
SPY554.540.22
+0.04%
SPDR® S&P 500® ETF
BTC.X94207.310000-77.476560
-0.08%
Bitcoin cryptocurrency
TSLA282.16-9.87
-3.38%
Tesla

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+2.94%
CRNX - ALT
45%
Loosely correlated
+0.24%
CLDX - ALT
44%
Loosely correlated
-0.48%
VKTX - ALT
44%
Loosely correlated
+3.33%
CCCC - ALT
43%
Loosely correlated
+3.80%
RCKT - ALT
42%
Loosely correlated
+4.81%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with NTLA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+4.81%
NTLA - RCKT
59%
Loosely correlated
+8.17%
RGNX - RCKT
58%
Loosely correlated
+2.13%
ETNB - RCKT
57%
Loosely correlated
+6.23%
DNLI - RCKT
56%
Loosely correlated
N/A
BEAM - RCKT
54%
Loosely correlated
+1.12%
More